Mesoblast Limited (ASX:MSB; USOTC:MBLTY)
Personal Information
Organization / Workplace
Mesoblast Limited (ASX:MSB; USOTC:MBLTY)Location
Melbourne AustraliaIndustry
Medical / Health Care / Pharmaceuticals
Website
mesoblast.com/About
Mesoblast Limited (ASX:MSB; USOTC:MBLTY) is developing novel biotherapeutics derived from its proprietary cell-based technologies. These technology platforms have the potential to deliver a diverse portfolio of clinical-stage products to treat a broad range of conditions with major unmet medical needs. The Company’s technology platforms have the potential to deliver a diverse portfolio of clinical-stage products to treat a broad range of conditions with major unmet medical needs. Its strategic product development focus is in four major and distinct areas - systemic inflammatory conditions, cardiovascular diseases, orthopedic diseases of the spine and oncology conditions.